An all-new Star Trek novel from New York Times bestselling author Greg Cox, taking place in the blockbuster Original Series era!
The year is 2255, not long after the events of the Original Series episode “The Cage.” A young Spock is science officer on the U.S.S. Enterprise, under the command of Captain Christopher Pike, when an outbreak of deadly Rigelian fever threatens the crew. Reviewing the Starfleet medical database, Dr. Phillip Boyce comes up with a highly experimental and untested new treatment that might save the crew. Just one problem: it requires a rare mineral substance, ryetalyn, which is not easily obtained... except on a remote alien colony near the Klingon border. But borders are somewhat blurry in this part of galaxy. Pike will need to tread carefully in order to avoid provoking an armed conflict with the Klingons — or starting an all-out war.
Greg Cox (born 1959) is a science fiction writer. He lives in Oxford, Pennsylvania, USA.
He has written numerous Star Trek novels, including The Eugenics Wars (Volume One and Two), The Q Continuum, Assignment: Eternity, and The Black Shore. His short fiction can be found in such anthologies as Star Trek: Tales of the Dominion War, Star Trek: The Amazing Stories and Star Trek: Enterprise logs. His first "Khan" novel, The Eugenics Wars: Volume One, was voted best sci-fi book of the year by the readers of Dreamwatch magazine. Cox can be found in a bonus feature on the "Director's Edition" DVD of Star Trek II: The Wrath of Khan.
Greg Cox. Wikipedia.